2. Take full advantage of re-usable components 

Starting every study build from scratch uses valuable staff time on similar tasks. An approach that leverages reusable components helps accelerate these timelines by eliminating manual, repetitive database-building tasks. 

Here’s how it works. 

After completing the first few studies, organizations can draw from re-usable components, which may include more than 100 case report forms with everything from demographics and vital signs to adverse events. They can use these from other areas of live studies, previous studies, or libraries. They can import standard forms when a new study comes in, and within a few hours, have a base study ready to show the client in four weeks instead of the standard 12-16 weeks. 

The independent authority of individual data managers and their use of the standard library contribute to this success. In addition, this accelerated-build approach directly benefits clients, who may receive standard templates the day after the kickoff meeting. They can visualize data capture in real time, leading to faster feedback and fewer misunderstandings later in the development cycle. 

3.  Adopt a modular mindset 

Clinical trials are rarely static. Protocols change, amendments occur, and new requirements emerge, necessitating a system that supports diverse functions, including electronic data capture, randomization, trial supply management, and electronic patient-reported outcomes. 

This modular flexibility enables teams to meet complex protocol requirements without overhauling the underlying system architecture. With a simpler user interface, everything resides in a single instance, and data flows in real time between modules. It’s also cost-effective, with payment only for the modules needed. Whether managing an intricate dosing schedule in an inventory module or handling specific language translation requirements in an eCOA tool, cross-training data managers on modular components helps stretch resources. Teams can manage simultaneous, multi-phase trial rollouts without a parallel spike in headcount.

The Operational Dividend 

Shifting to a unified, efficient data management strategy yields dividends that extend far beyond the data team itself. 

• Elevated Leadership Focus: When the technical execution of study builds is streamlined and dependable, clinical operations leaders can pivot away from day-to-day mechanics and focus on process optimization, strategic growth, and sponsor relations. 
  
  
• Cultivated Sponsor Trust: Speed should never come at the cost of quality. A standardized operational framework allows teams to execute complex protocol amendments and user acceptance testing in fractions of the time required by traditional methods, establishing the data function as a true strategic partner. 
  
• Lean Resource Optimization: With scalable technical resources, a skilled data manager can build and maintain studies that historically require a team of four or five technical staff members. 

Ultimately, the intersection of adaptable talent and scalable technology drives efficiency in clinical data management. By removing unnecessary technical barriers and standardizing core components, clinical organizations can remain lean, stay focused, and deliver high-quality data at the pace required by modern drug development. 

Deepa Avinash is the head of data management at ClinicalDM by Inventiv Matrix, bringing two decades of expertise in life sciences research and healthcare technology. Throughout her career, she has partnered extensively with global pharmaceutical companies to optimize data collection in clinical trials and has a proven track record of success. A technical specialist in clinical ecosystem integration, Deepa possesses deep expertise in EDC, RTSM, and ePRO systems and currently uses Zelta. Her work focuses on leveraging technology to drive data integrity and operational efficiency in complex global studies.  Deepa can be reached at davinash@ClinicalDM.com.